BUX.CN
BioMark Diagnostics Inc
Price:  
0.32 
CAD
Volume:  
4,500.00
Canada | N/A
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

BUX.CN Relative Valuation

-130.0%
Upside

As of 2025-06-20, the Relative Valuation of BioMark Diagnostics Inc (BUX.CN) is (0.10) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.32 CAD, the upside of BioMark Diagnostics Inc based on Relative Valuation is -130.0%.

The range of the Relative Valuation is (0.05) - (0.15) CAD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 2.5x - 8.2x 5.4x
Forward P/E multiples 2.4x - 8.2x 5.3x
Fair Price (0.05) - (0.15) (0.10)
Upside -114.1% - -146.1% -130.0%
0.32 CAD
Stock Price
(0.10) CAD
Fair Price

BUX.CN Relative Valuation - Historical P/E Data

Date P/E
2025-06-05 -18.28
2025-06-04 -18.28
2025-06-03 -17.73
2025-06-02 -16.62
2025-05-30 -16.62
2025-05-29 -16.62
2025-05-27 -16.62
2025-05-26 -16.62
2025-05-23 -16.62
2025-05-22 -16.07
2025-05-21 -16.62
2025-05-20 -16.62
2025-05-16 -14.96
2025-05-14 -15.51
2025-05-13 -15.51
2025-05-08 -15.51
2025-05-06 -15.51
2025-05-05 -15.51
2025-05-01 -14.41
2025-04-30 -14.13
2025-04-29 -13.85
2025-04-25 -13.85
2025-04-17 -13.85
2025-04-16 -13.85
2025-04-15 -13.57
2025-04-14 -13.85
2025-04-11 -13.85
2025-04-10 -13.85
2025-04-09 -14.13
2025-04-08 -14.41
2025-04-07 -14.13
2025-04-04 -14.41
2025-04-03 -14.41
2025-04-02 -13.85
2025-04-01 -14.96
2025-03-31 -14.96
2025-03-26 -13.85
2025-03-25 -14.41
2025-03-24 -14.41
2025-03-21 -14.13
2025-03-20 -13.57